Ładuje się......
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomized placebo-controlled trial
BACKGROUND: Treatment-resistant major depressive disorder is common and potentially life-threatening in older persons, in whom little is known about the benefits and risks of augmentation pharmacotherapy. METHODS: We conducted a multi-site, placebo-controlled, randomized clinical trial to test the e...
Zapisane w:
| Wydane w: | Lancet |
|---|---|
| Główni autorzy: | , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4690746/ https://ncbi.nlm.nih.gov/pubmed/26423182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)00308-6 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|